CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Novartis Corporation v. Teva Parenteral Medicines Inc.

1:08-cv-00952

Overview

Case Number 1:08-cv-00952
Filing Date 2008-12-18
Status Terminated
Termination Date 2010-08-16
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Teva Parenteral Medicines Inc. Operating Company

Represented By

2 Attorneys Listed

Keith A. Zullow

Email: kzullow@goodwinprocter.com

Richard D. Kirk

Bayard, P.A.

Tel: +1 (302) 429-4208
Fax: +1 (302) 658-6395

Bayard, P.A., 222 Delaware Avenue, Suite 900

Teva Pharmaceuticals USA Inc. Operating Company

Represented By

1 Attorneys Listed

Richard D. Kirk

Bayard, P.A.

Tel: +1 (302) 429-4208
Fax: +1 (302) 658-6395

Bayard, P.A., 222 Delaware Avenue, Suite 900

Teva Pharmaceutical Industries Ltd. Operating Company

Represented By

1 Attorneys Listed

Richard D. Kirk

Bayard, P.A.

Tel: +1 (302) 429-4208
Fax: +1 (302) 658-6395

Bayard, P.A., 222 Delaware Avenue, Suite 900

Novartis Corporation Operating Company

Represented By

7 Attorneys Listed

Vinita Ferrera

Email: vinita.ferrera@wilmerhale.com

Anne M. McLaughlin

UNDELIVERABLE EMAIL 8/28/13

William F. Lee

Pro Hac Vice

Pro Hac Vice

Allen C. Nunnally

Email: allen.nunnally@wilmerhale.com

Lisa J. Pirozzolo

Pro Hac Vice

Pro Hac Vice

Daniel M. Esrick

Email: daniel.esrick@wilmerhale.com

Anne Shea Gaza

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6727

Rodney Square, 1000 North King Street

Novartis Pharmaceuticals Corporation Operating Company

Represented By

1 Attorneys Listed

Anne Shea Gaza

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6727

Rodney Square, 1000 North King Street

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (1): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US4939130
Substituted alkanediphosphonic acids and pharmaceutical use
Filed: 1989-02-27
Issued: 1990-07-03
Expired (Term Ended) +1283d PTA
Expires: 2012-09-02

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+1283 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Docket Entries

(20 total)
Pleading / Complaint

COMPLAINT filed against Teva Parenteral Medicines Inc., Teva Pharmaceuticals USA Inc., Teva Pharmaceutical Industries Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 03110000000000531302.) - filed by Novartis Corporation, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dzs, ) (Entered: 12/19/2008)

Entry #1 • 2008-12-18
1

Notice of Availability of a U.S. Magistrate Judge to Exercise Jurisdiction (dzs, ) (Entered: 12/19/2008)

Entry #2 • 2008-12-18
1

Disclosure Statement pursuant to Rule 7.1 filed by Novartis Corporation, Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis AG for Novartis Corporation, Novartis Pharmaceuticals Corporation. (dzs, ) (Entered: 12/19/2008)

Entry #3 • 2008-12-18
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 4,939,130; (dzs, ) (Entered: 12/19/2008)

Entry #4 • 2008-12-19
1
Pleading / Complaint

Return of Service Executed by Novartis Corporation, Novartis Pharmaceuticals Corporation. Teva Pharmaceuticals USA Inc. served on 12/18/2008, answer due 1/7/2009. (Cottrell, Frederick) (Entered: 12/19/2008)

Entry #5 • 2008-12-19
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc